Dr. Mirjam-Colette Kempf UAB MWCCS Co-Principal Investigator
Last week, our very own MWCCS Principal Investigator, Dr. Mirjam-Colette Kempf, and the MWCCS Neurocognitive Working Group Co-Chair, Dr. David Vance, were among three faculty members from the University of Alabama at Birmingham (UAB) School of Nursing who received the rank of University Professorships. This honor is awarded to those whose groundbreaking work transcends multiple disciplines, enabling them to conduct research across various UAB schools. Both Dr. Kempf and Dr. Vance have made significant scientific contributions that have garnered academic distinction across disciplinary lines. Their achievements not only reflect their individual excellence but also enhance the reputation of our institution. Congratulations to you both!!!!!
Dr. David Vance MWCCS Neurocognitive Working Group Co-Chair
Dr. Emily Levitan, PhD Associate Professor, Epidemiology
We are pleased to announce that Dr. Emily Levitan, a Professor at the UAB School of Public Health, has been appointed as a Co-Principal Investigator for the UAB Multicenter AIDS Cohort Study/Women’s Interagency HIV Study (MWCCS). Dr. Levitan joins Dr. Mirjam-Colette Kempf in this leadership role, bringing a wealth of expertise and dedication to our research initiative.
Dr. Levitan received her Doctoral training at Harvard’s School of Public Health. She became a part of the UAB family in 2009. Her contributions to epidemiology and public health have been widely recognized, making her an invaluable addition to our team. Her primary commitment is to improve public health through population research using traditional epidemiologic studies and administrative data with an emphasis on cardiovascular disease and the long-term effects of HIV and COVID-19. Dr. Levitan’s research projects also focus on the primary and secondary prevention of heart failure and other cardiovascular diseases. She is co-PI of numerous cohort including REGARDS-MI, which is a longitudinal study evaluating cardiovascular disease incidence and outcomes in this diverse nationwide cohort, and the Deep South SARS-CoV-2 Recovery Cohort, one of the cohorts of adults contributing to the NIH RECOVER Initiative which examine the effects of long COVID.
Together with Dr. Kempf, Dr. Levitan will play a pivotal role in advancing the objectives of the UAB MWCCS, focusing on the study’s scientific initiatives. Their collaborative efforts promise to enhance our understanding of the focus of HIV/AIDS and its impact on public health outcomes.
Please join me in welcoming Dr. Emily Levitan to her new role as Co-Principal Investigator of the UAB MWCCS. We look forward to her leadership and contributions to achieving our research goals.
UAB is an Equal Employment/Equal Educational Opportunity Institution dedicated to providing equal opportunities and equal access to all individuals regardless of race, color, religion, ethnic or national origin, sex (including pregnancy), genetic information, age, disability, religion, sexual orientation, gender identity, gender expression, and veteran’s status. As required by Title IX, UAB prohibits sex discrimination in any education program or activity that it operates. Individuals may report concerns or questions to UAB’s Assistant Vice President and Senior Title IX Coordinator. The Title IX notice of nondiscrimination is located at uab.edu/titleix.
